I haven't had much time to update the blog this week as I have had some other things going on that have been taking up my time.
Overall it has been a good week. I have been very selective and quick to take profits or cut losses. Tomorrow is Good Friday so the Stock market is closed.
Here is what caught my eye so far this morning.
$RPRX pr, $GTAT pr already in for swing, $HIMX, $ONCY Pr,$HALO possible bounce play, $MNKD flag,$GEVO, $ANAD,$HEK,$CADX upgrade, $BSX, $FREE, $RDN,$ANTH, $EDAP PR, $AAV pr upgrade
Seeking Alpha
Today's Markets:
In Asia, Japan -1.3% to 12336. Hong Kong -0.7% to 22300. China -2.8% to 2236. India +0.7% to 18836.
In Europe, at midday, London +0.5%. Paris +0.3%. Frankfurt +0.4%.
Futures at 7:00: Dow +0.1%. S&P +0.1%. Nasdaq +0.2%. Crude +0.2% to $96.75. Gold -0.2% to $1603.35.
Today's economic calendar:
8:30 Initial Jobless Claims
8:30 GDP Q4
8:30 Corporate Profits
9:45 Bloomberg Consumer Comfort Index
9:45 Chicago PMI
10:30 EIA Natural Gas Inventory
11:00 Kansas City Fed Mfg Survey
1:00 PM Results of $29B, 7-Year Note Auction
4:30 PM Money Supply
4:30 PM Fed Balance Sheet
Notable earnings before today's open: ACN, BBRY, CMC, FINL, GME, MOS
Notable earnings after today's close: None
Briefing.com
Gapping Up
In reaction to strong earnings/guidance: BAMM +8.8%
(thinly traded), VRNT
+6.2% (light volume), XONE +5.6%.
M&A news: LCC +2.4% (reports indicate US Airways and
American Airlines merger
has received Court approval; also US Airways' PSA
Airlines Pilots ratify new contract) .
Select financial related names showing strength: GNW +2%
(announced the sale
of its Wealth Management unit for ~$412 mln), BCS +1.8%
(Liberty Global acquires a 12.65% Stake in Ziggo from Barclays unit), DB +1.6%, HBC +1.1%.
Other news: RPRX +75.2% (reports both primary endpoints
successfully met in
first pivotal study of Androxal), CTIC +11.5% (Cell
Therapeutics secures $15 mln loan financing agreement), ANTH +10.9% (announced it has initiated the
CHABLIS-SC1 Phase 3 study of blisibimod, a novel inhibitor of B-Cell
Activating Factor (BAFF) for the treatment of lupus), ONCY +7% (Oncolytics
Biotech meets primary overall statistical endpoint in Phase 2 study of
REOLYSIN in squamous cell lung cancer), GBX +6.6% (announced new orders of
5,400 railcars valued at $575 mln, NGG +2.6% (still checking), BIIB +1.8%
(following late strength on FDA approval news; confirmed after the close), BUD
+1.3% (still checking), BP +0.6% ( to proceed with a two-year appraisal
programme to look at the possibility of developing a third phase of the giant
Clair field, west of the Shetland Islands), RDA +0.5% (prices 8.35 mln ADS
follow-on offering by co and certain shareholders at $9.25 per ADS), .
Analyst comments: DECK +2.2% (tgt to $100 from $65 at Jefferies), RYAAY +0.8%
(ticking higher, upgraded to Buy from Neutral at Citigroup
GAPPING Down
FIVE -6.8%, RAS -4.2%, PVH -4.2%, FIG
-4.1%, RHT -3.9%, AEGN
-3.8%, SJW -3.6%, SCS -3.2%, TUMI -1.9%, TEF -1.8%, CHKP
-1.4%, BHP -1.3%, RIO
-1.2%, DG -1.1%, CTXS -1%
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
No comments:
Post a Comment